A prescription app takes on PTSD: can digital therapy replace the couch?

NCT ID NCT06868446

Completed Symptom relief Sponsor: Oui Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This study is testing a prescription digital therapeutic app, OTX-601, designed to deliver evidence-based PTSD treatment through a smartphone. Researchers are comparing two versions of the app—one with a higher 'dose'—against standard care (therapy and/or medication) in 40 adults diagnosed with PTSD. The goal is to see whether the app can reduce PTSD symptoms and whether users find it easy and acceptable to use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a prescription digital therapeutic app called OTX-601
What this could lead to: If effective, this app could offer a new, accessible treatment option for PTSD that can be used at home.
What could go wrong: This is an early-phase trial with only 40 participants, so results may not apply broadly. The app may not outperform standard therapy, and digital interventions can have variable user engagement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POST-TRAUMATIC STRESS DISORDER PTSD

Contacts and locations

Locations

Florida State University

Tallahassee, Florida, 32306, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.